Table 2.
Mapping and ablation of VAs in the transaortic group, transseptal group and trans-DGCV group
| Group | Time of earliest ventricular activation preceding QRS onset, ms | Number of similar lead counts between spontaneous PVCs and Pace | RF lesions prior to success | Target site discharge time for PVCs/VT disappearance, s | Ablation time, s | Procedure time, min | X-ray exposure time, min |
|---|---|---|---|---|---|---|---|
| TA | 33.95 ± 5.43a | 10.94 ± 1.87† | 2.58 ± 1.59a | 7.4 ± 3.4 a | 139.9 ± 32.4* | 70.23 ± 22.95a | 9.41 ± 3.92a |
| TS | 28.23 ± 2.26 | 6.67 ± 4.56 | 5.94 ± 3.28 | 10.7 ± 5.2 | 366.9 ± 78.4 | 85.68 ± 21.94 | 19.08 ± 3.36 |
| TGCV | 35.54 ± 6.44 | 11.5 ± 0.7 | 2.08 ± 1.23a | 7.5 ± 3.1a | 289.4 ± 58.4‡ | 70.61 ± 21.85a | 10.19 ± 3.94a |
Data are presented as mean + SD or n (%). Annotation: TA = Transaortic group, TS = Transseptal group, TGCV Trans-DGCV group. Compared with TS, a P < 0.01, † P < 0.05; and compared with TGCV, ‡ P < 0.01